Key terms
About DERM
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest DERM news
Mar 18
8:33am ET
Journey Medical announces U.S. FDA acceptance of NDA for DFD-29
Mar 11
8:36am ET
Journey Medical presents data from Phase 1 trial of DFD-29
Feb 16
7:04am ET
Journey Medical initiated with a Buy at Alliance Global Partners
Jan 05
8:32am ET
Journey Medical submits NDA to FDA for DFD-29
Dec 26
9:42am ET
Journey Medical Corp trading resumes
Dec 26
9:32am ET
Journey Medical Corp trading halted, volatility trading pause
No recent news articles are available for DERM
No recent press releases are available for DERM
DERM Financials
Key terms
Ad Feedback
DERM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
DERM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
